CN Stock MarketDetailed Quotes

300677 Intco Medical Technology

Watchlist
  • 24.79
  • +0.82+3.42%
Market Closed Apr 25 15:00 CST
16.06BMarket Cap20.74P/E (TTM)

Intco Medical Technology Key Stats

All
YOY yoy
Hide blank lines yoy
(Q3)Mar 31, 2024
(FY)Dec 31, 2023
(Q9)Sep 30, 2023
(Q6)Jun 30, 2023
(Q3)Mar 31, 2023
(FY)Dec 31, 2022
(Q9)Sep 30, 2022
(Q6)Jun 30, 2022
(Q3)Mar 31, 2022
(FY)Dec 31, 2021
Total operating revenue
40.06%2.2B
4.61%6.92B
-3.27%5.04B
-11.91%3.29B
-31.25%1.57B
-59.27%6.61B
-61.81%5.21B
-64.96%3.74B
-66.03%2.29B
17.37%16.24B
Operating revenue
40.06%2.2B
4.61%6.92B
-3.27%5.04B
-11.91%3.29B
-31.25%1.57B
-59.27%6.61B
-61.81%5.21B
-64.96%3.74B
-66.03%2.29B
17.37%16.24B
Other operating revenue
----
35.11%31.36M
----
-32.15%13.16M
----
-0.31%23.21M
----
8.70%19.4M
----
581.70%23.28M
Total operating cost
13.93%1.99B
11.60%6.75B
7.03%4.8B
-7.70%3B
-20.23%1.74B
-20.18%6.05B
-19.20%4.48B
-12.85%3.25B
-3.49%2.19B
38.52%7.58B
Operating cost
20.39%1.75B
3.92%5.97B
-1.45%4.4B
-4.54%2.94B
-22.36%1.45B
-8.09%5.75B
-4.70%4.47B
-1.82%3.08B
-5.93%1.87B
45.89%6.25B
Operating tax surcharges
-8.52%15.37M
21.48%67.29M
16.70%46.39M
12.98%32.28M
5.18%16.8M
25.69%55.39M
21.19%39.75M
24.80%28.57M
31.46%15.98M
-21.36%44.07M
Operating expense
33.52%67.9M
15.60%251.8M
1.47%178.32M
6.34%109.03M
-48.11%50.85M
-43.23%217.83M
-33.55%175.73M
-42.87%102.54M
-7.03%98.01M
18.56%383.71M
Administration expense
0.72%118.17M
19.44%486.51M
15.30%379.06M
8.64%243.22M
2.87%117.34M
-26.67%407.32M
-12.77%328.76M
-4.99%223.88M
9.67%114.07M
123.03%555.47M
Financial expense
-207.29%-46.77M
51.15%-306.44M
43.68%-409.37M
-41.37%-457.09M
129.55%43.59M
-3,170.38%-627.25M
-832.76%-726.9M
-1,074.88%-323.33M
140.60%18.99M
-107.23%-19.18M
-Interest expense (Financial expense)
289.09%58.42M
348.84%127.74M
365.06%83.17M
269.20%44.67M
196.63%15.02M
61.66%28.46M
56.67%17.88M
71.68%12.1M
33.32%5.06M
-17.35%17.61M
-Interest Income (Financial expense)
-44.25%-99.4M
-180.10%-308.71M
-285.57%-210.4M
-337.30%-131.99M
-461.02%-68.91M
23.54%-110.21M
51.47%-54.57M
54.99%-30.18M
36.96%-12.28M
-252.39%-144.15M
Research and development
32.40%84.58M
12.31%283.37M
1.44%201.28M
-4.58%133.71M
-8.18%63.88M
-30.91%252.32M
-25.00%198.42M
-23.85%140.13M
-32.44%69.57M
24.52%365.22M
Credit Impairment Loss
-245.43%-14.92M
-367.03%-24.36M
-182.53%-13.66M
-177.77%-11.27M
-129.41%-4.32M
115.66%9.12M
139.22%16.55M
158.29%14.49M
127.21%14.69M
-282.43%-58.26M
Asset Impairment Loss
---367.07K
87.85%-5.35M
95.33%-681.39K
96.55%-681.39K
----
-666.74%-44.04M
-2,766.90%-14.59M
-7,703.07%-19.75M
----
-300.66%-5.74M
Other net revenue
260.39%77.54M
89.23%273.83M
75.91%226.1M
183.31%153.62M
182.59%21.52M
389.57%144.7M
2,468.17%128.53M
411.94%54.22M
117.08%7.61M
494.31%29.56M
Fair value change income
1,609.83%64.17M
194.23%175.57M
99.38%123.04M
490.89%88.76M
82.73%-4.25M
82.70%59.67M
225.84%61.71M
-3.51%15.02M
-511.73%-24.62M
928.50%32.66M
Invest income
29.72%20.89M
5.01%87.45M
161.25%78.2M
299.70%51.87M
--16.1M
192.61%83.27M
1,634.60%29.93M
--12.98M
----
504.20%28.46M
Asset deal income
-0.95%15.89K
-91.00%213.38K
107.81%44.43K
107.92%44.43K
101.22%16.04K
526.93%2.37M
-265.02%-569.17K
-262.59%-560.78K
-284.87%-1.31M
2,407.79%378.07K
Other revenue
-44.49%7.75M
17.52%40.31M
10.29%39.15M
-22.30%24.9M
-25.93%13.96M
6.98%34.3M
33.02%35.5M
61.98%32.05M
389.18%18.85M
133.36%32.07M
Operating profit
295.31%293.16M
-37.92%438.99M
-45.27%469.13M
-17.68%444.35M
-238.32%-150.1M
-91.86%707.18M
-89.42%857.12M
-92.23%539.79M
-97.55%108.52M
3.82%8.69B
Add:Non operating Income
-20.76%466.33K
55.09%38.34M
-74.90%1.66M
-43.17%1.05M
-44.40%588.5K
226.65%24.72M
91.51%6.63M
-46.70%1.85M
223.78%1.06M
-1.44%7.57M
Less:Non operating expense
-77.04%1.27M
25.54%34.51M
22.19%29.42M
26.15%20.78M
17.74%5.53M
-42.24%27.49M
68.51%24.08M
234.55%16.48M
119.86%4.7M
58.83%47.6M
Total profit
288.57%292.36M
-37.14%442.82M
-47.43%441.37M
-19.15%424.62M
-247.83%-155.04M
-91.86%704.41M
-89.62%839.66M
-92.44%525.17M
-97.63%104.88M
3.62%8.65B
Less:Income tax cost
725.95%51.79M
-15.86%54.75M
-49.65%104.11M
-0.84%120.13M
-132.57%-8.27M
-94.51%65.07M
-81.62%206.78M
-88.66%121.15M
-96.31%25.4M
-11.69%1.19B
Net profit
FLtoP240.57M
-39.30%388.06M
-46.71%337.26M
-24.63%304.49M
SL-146.77M
-91.43%639.34M
-90.92%632.88M
-93.13%404.01M
-97.87%79.47M
6.55%7.46B
Net profit from continuing operation
263.91%240.57M
-39.30%388.06M
-46.71%337.26M
-24.63%304.49M
-284.68%-146.77M
-91.43%639.34M
-90.92%632.88M
-93.13%404.01M
-97.87%79.47M
6.55%7.46B
Less:Minority Profit
-62.34%2.37M
-50.68%5.07M
213.00%6.41M
577.57%11.33M
256.34%6.29M
-69.24%10.27M
-123.47%-5.67M
-9.11%1.67M
-170.75%-4.02M
1,416.46%33.4M
Net profit of parent company owners
255.63%238.2M
-39.12%383M
-48.19%330.85M
-27.14%293.16M
-283.32%-153.06M
-91.53%629.07M
-90.80%638.55M
-93.16%402.34M
-97.77%83.49M
6.04%7.43B
Earning per share
Basic earning per share
256.52%0.36
-38.95%0.58
-48.45%0.5
-27.87%0.44
-276.92%-0.23
-91.62%0.95
-91.02%0.97
-93.18%0.61
-98.20%0.13
-22.66%11.33
Diluted earning per share
256.52%0.36
-38.95%0.58
-48.45%0.5
-27.87%0.44
-276.92%-0.23
-91.36%0.95
-90.67%0.97
-92.84%0.61
-98.11%0.13
-18.94%11
Other composite income
163.39%3.37M
-140.14%-11.21M
-221.26%-21.58M
-801.80%-23.9M
-70.76%-5.32M
567.03%27.93M
1,198.93%17.79M
215.19%3.41M
-154.81%-3.11M
66.35%-5.98M
Other composite income of parent company owners
163.39%3.37M
-140.14%-11.21M
-221.26%-21.58M
-801.80%-23.9M
-70.76%-5.32M
567.03%27.93M
1,198.93%17.79M
215.19%3.41M
-154.81%-3.11M
66.35%-5.98M
Total composite income
260.39%243.94M
-43.52%376.85M
-51.48%315.68M
-31.13%280.59M
-299.18%-152.09M
-91.05%667.27M
-90.66%650.67M
-93.07%407.42M
-97.96%76.36M
6.74%7.46B
Total composite income of parent company owners
252.53%241.57M
-43.41%371.79M
-52.88%309.27M
-33.64%269.26M
-297.03%-158.37M
-91.15%657M
-90.54%656.34M
-93.09%405.74M
-97.85%80.38M
6.22%7.42B
Total composite income of minority owners
-62.34%2.37M
-50.68%5.07M
213.00%6.41M
577.57%11.33M
256.34%6.29M
-69.24%10.27M
-123.47%-5.67M
-9.11%1.67M
-170.75%-4.02M
1,416.46%33.4M
Currency Unit
CNY
CNY
CNY
CNY
CNY
CNY
CNY
CNY
CNY
CNY
Accounting Standards
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
Audit Opinions
--
Unqualified opinion
--
--
--
Unqualified opinion
--
--
--
Unqualified opinion
Auditor
--
PricewaterhouseCoopers Zhongtian Certified Public Accountants (Special General Partnership)
--
--
--
PricewaterhouseCoopers Zhongtian Certified Public Accountants (Special General Partnership)
--
--
--
PricewaterhouseCoopers Zhongtian Certified Public Accountants (Special General Partnership)
(Q3)Mar 31, 2024(FY)Dec 31, 2023(Q9)Sep 30, 2023(Q6)Jun 30, 2023(Q3)Mar 31, 2023(FY)Dec 31, 2022(Q9)Sep 30, 2022(Q6)Jun 30, 2022(Q3)Mar 31, 2022(FY)Dec 31, 2021
Total operating revenue 40.06%2.2B4.61%6.92B-3.27%5.04B-11.91%3.29B-31.25%1.57B-59.27%6.61B-61.81%5.21B-64.96%3.74B-66.03%2.29B17.37%16.24B
Operating revenue 40.06%2.2B4.61%6.92B-3.27%5.04B-11.91%3.29B-31.25%1.57B-59.27%6.61B-61.81%5.21B-64.96%3.74B-66.03%2.29B17.37%16.24B
Other operating revenue ----35.11%31.36M-----32.15%13.16M-----0.31%23.21M----8.70%19.4M----581.70%23.28M
Total operating cost 13.93%1.99B11.60%6.75B7.03%4.8B-7.70%3B-20.23%1.74B-20.18%6.05B-19.20%4.48B-12.85%3.25B-3.49%2.19B38.52%7.58B
Operating cost 20.39%1.75B3.92%5.97B-1.45%4.4B-4.54%2.94B-22.36%1.45B-8.09%5.75B-4.70%4.47B-1.82%3.08B-5.93%1.87B45.89%6.25B
Operating tax surcharges -8.52%15.37M21.48%67.29M16.70%46.39M12.98%32.28M5.18%16.8M25.69%55.39M21.19%39.75M24.80%28.57M31.46%15.98M-21.36%44.07M
Operating expense 33.52%67.9M15.60%251.8M1.47%178.32M6.34%109.03M-48.11%50.85M-43.23%217.83M-33.55%175.73M-42.87%102.54M-7.03%98.01M18.56%383.71M
Administration expense 0.72%118.17M19.44%486.51M15.30%379.06M8.64%243.22M2.87%117.34M-26.67%407.32M-12.77%328.76M-4.99%223.88M9.67%114.07M123.03%555.47M
Financial expense -207.29%-46.77M51.15%-306.44M43.68%-409.37M-41.37%-457.09M129.55%43.59M-3,170.38%-627.25M-832.76%-726.9M-1,074.88%-323.33M140.60%18.99M-107.23%-19.18M
-Interest expense (Financial expense) 289.09%58.42M348.84%127.74M365.06%83.17M269.20%44.67M196.63%15.02M61.66%28.46M56.67%17.88M71.68%12.1M33.32%5.06M-17.35%17.61M
-Interest Income (Financial expense) -44.25%-99.4M-180.10%-308.71M-285.57%-210.4M-337.30%-131.99M-461.02%-68.91M23.54%-110.21M51.47%-54.57M54.99%-30.18M36.96%-12.28M-252.39%-144.15M
Research and development 32.40%84.58M12.31%283.37M1.44%201.28M-4.58%133.71M-8.18%63.88M-30.91%252.32M-25.00%198.42M-23.85%140.13M-32.44%69.57M24.52%365.22M
Credit Impairment Loss -245.43%-14.92M-367.03%-24.36M-182.53%-13.66M-177.77%-11.27M-129.41%-4.32M115.66%9.12M139.22%16.55M158.29%14.49M127.21%14.69M-282.43%-58.26M
Asset Impairment Loss ---367.07K87.85%-5.35M95.33%-681.39K96.55%-681.39K-----666.74%-44.04M-2,766.90%-14.59M-7,703.07%-19.75M-----300.66%-5.74M
Other net revenue 260.39%77.54M89.23%273.83M75.91%226.1M183.31%153.62M182.59%21.52M389.57%144.7M2,468.17%128.53M411.94%54.22M117.08%7.61M494.31%29.56M
Fair value change income 1,609.83%64.17M194.23%175.57M99.38%123.04M490.89%88.76M82.73%-4.25M82.70%59.67M225.84%61.71M-3.51%15.02M-511.73%-24.62M928.50%32.66M
Invest income 29.72%20.89M5.01%87.45M161.25%78.2M299.70%51.87M--16.1M192.61%83.27M1,634.60%29.93M--12.98M----504.20%28.46M
Asset deal income -0.95%15.89K-91.00%213.38K107.81%44.43K107.92%44.43K101.22%16.04K526.93%2.37M-265.02%-569.17K-262.59%-560.78K-284.87%-1.31M2,407.79%378.07K
Other revenue -44.49%7.75M17.52%40.31M10.29%39.15M-22.30%24.9M-25.93%13.96M6.98%34.3M33.02%35.5M61.98%32.05M389.18%18.85M133.36%32.07M
Operating profit 295.31%293.16M-37.92%438.99M-45.27%469.13M-17.68%444.35M-238.32%-150.1M-91.86%707.18M-89.42%857.12M-92.23%539.79M-97.55%108.52M3.82%8.69B
Add:Non operating Income -20.76%466.33K55.09%38.34M-74.90%1.66M-43.17%1.05M-44.40%588.5K226.65%24.72M91.51%6.63M-46.70%1.85M223.78%1.06M-1.44%7.57M
Less:Non operating expense -77.04%1.27M25.54%34.51M22.19%29.42M26.15%20.78M17.74%5.53M-42.24%27.49M68.51%24.08M234.55%16.48M119.86%4.7M58.83%47.6M
Total profit 288.57%292.36M-37.14%442.82M-47.43%441.37M-19.15%424.62M-247.83%-155.04M-91.86%704.41M-89.62%839.66M-92.44%525.17M-97.63%104.88M3.62%8.65B
Less:Income tax cost 725.95%51.79M-15.86%54.75M-49.65%104.11M-0.84%120.13M-132.57%-8.27M-94.51%65.07M-81.62%206.78M-88.66%121.15M-96.31%25.4M-11.69%1.19B
Net profit FLtoP240.57M-39.30%388.06M-46.71%337.26M-24.63%304.49MSL-146.77M-91.43%639.34M-90.92%632.88M-93.13%404.01M-97.87%79.47M6.55%7.46B
Net profit from continuing operation 263.91%240.57M-39.30%388.06M-46.71%337.26M-24.63%304.49M-284.68%-146.77M-91.43%639.34M-90.92%632.88M-93.13%404.01M-97.87%79.47M6.55%7.46B
Less:Minority Profit -62.34%2.37M-50.68%5.07M213.00%6.41M577.57%11.33M256.34%6.29M-69.24%10.27M-123.47%-5.67M-9.11%1.67M-170.75%-4.02M1,416.46%33.4M
Net profit of parent company owners 255.63%238.2M-39.12%383M-48.19%330.85M-27.14%293.16M-283.32%-153.06M-91.53%629.07M-90.80%638.55M-93.16%402.34M-97.77%83.49M6.04%7.43B
Earning per share
Basic earning per share 256.52%0.36-38.95%0.58-48.45%0.5-27.87%0.44-276.92%-0.23-91.62%0.95-91.02%0.97-93.18%0.61-98.20%0.13-22.66%11.33
Diluted earning per share 256.52%0.36-38.95%0.58-48.45%0.5-27.87%0.44-276.92%-0.23-91.36%0.95-90.67%0.97-92.84%0.61-98.11%0.13-18.94%11
Other composite income 163.39%3.37M-140.14%-11.21M-221.26%-21.58M-801.80%-23.9M-70.76%-5.32M567.03%27.93M1,198.93%17.79M215.19%3.41M-154.81%-3.11M66.35%-5.98M
Other composite income of parent company owners 163.39%3.37M-140.14%-11.21M-221.26%-21.58M-801.80%-23.9M-70.76%-5.32M567.03%27.93M1,198.93%17.79M215.19%3.41M-154.81%-3.11M66.35%-5.98M
Total composite income 260.39%243.94M-43.52%376.85M-51.48%315.68M-31.13%280.59M-299.18%-152.09M-91.05%667.27M-90.66%650.67M-93.07%407.42M-97.96%76.36M6.74%7.46B
Total composite income of parent company owners 252.53%241.57M-43.41%371.79M-52.88%309.27M-33.64%269.26M-297.03%-158.37M-91.15%657M-90.54%656.34M-93.09%405.74M-97.85%80.38M6.22%7.42B
Total composite income of minority owners -62.34%2.37M-50.68%5.07M213.00%6.41M577.57%11.33M256.34%6.29M-69.24%10.27M-123.47%-5.67M-9.11%1.67M-170.75%-4.02M1,416.46%33.4M
Currency Unit CNYCNYCNYCNYCNYCNYCNYCNYCNYCNY
Accounting Standards CAS (2007)CAS (2007)CAS (2007)CAS (2007)CAS (2007)CAS (2007)CAS (2007)CAS (2007)CAS (2007)CAS (2007)
Audit Opinions --Unqualified opinion------Unqualified opinion------Unqualified opinion
Auditor --PricewaterhouseCoopers Zhongtian Certified Public Accountants (Special General Partnership)------PricewaterhouseCoopers Zhongtian Certified Public Accountants (Special General Partnership)------PricewaterhouseCoopers Zhongtian Certified Public Accountants (Special General Partnership)

FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.

Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List
CN
Overall
Symbol
Latest Price
%Chg